bluebird bio (NASDAQ:BLUE) is set to reduce its approximately 25% of its workforce as part of a restructuring plan intended to optimize cost structure. The restructuring is expected to result in a ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
When Logan Parker first sees a male, black-throated blue warbler near his Maine home each spring, two things strike him about the tiny bird – its stunning appearance and the thousands of miles ...